List of Tables
Table 1. Global Targeted Therapy Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Targeted Therapy Drugs Market Value by Administration Route (US$ Million), 2025 vs 2032
Table 3. Global Targeted Therapy Drugs Market Value by Molecular Properties (US$ Million), 2025 vs 2032
Table 4. Global Targeted Therapy Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Targeted Therapy Drugs Market Competitive Situation by Manufacturers in 2025
Table 6. Global Targeted Therapy Drugs Sales (M Units) of Key Manufacturers (2021–2026)
Table 7. Global Targeted Therapy Drugs Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Targeted Therapy Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Targeted Therapy Drugs Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Targeted Therapy Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Targeted Therapy Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Targeted Therapy Drugs, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Targeted Therapy Drugs, Product Types and Applications
Table 14. Global Key Manufacturers of Targeted Therapy Drugs, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Targeted Therapy Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Targeted Therapy Drugs Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Targeted Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Targeted Therapy Drugs Sales by Region (M Units), 2021–2026
Table 20. Global Targeted Therapy Drugs Sales Market Share by Region (2021–2026)
Table 21. Global Targeted Therapy Drugs Sales by Region (M Units), 2027–2032
Table 22. Global Targeted Therapy Drugs Sales Market Share by Region (2027–2032)
Table 23. Global Targeted Therapy Drugs Revenue by Region (US$ Million), 2021–2026
Table 24. Global Targeted Therapy Drugs Revenue Market Share by Region (2021–2026)
Table 25. Global Targeted Therapy Drugs Revenue by Region (US$ Million), 2027–2032
Table 26. Global Targeted Therapy Drugs Revenue Market Share by Region (2027–2032)
Table 27. North America Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
Table 29. North America Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
Table 30. North America Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
Table 31. North America Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
Table 34. Europe Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
Table 35. Europe Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Targeted Therapy Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Targeted Therapy Drugs Sales by Region (M Units), 2021–2026
Table 39. Asia Pacific Targeted Therapy Drugs Sales by Region (M Units), 2027–2032
Table 40. Asia Pacific Targeted Therapy Drugs Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Targeted Therapy Drugs Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
Table 44. Latin America Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
Table 45. Latin America Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
Table 49. Middle East and Africa Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
Table 50. Middle East and Africa Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
Table 52. Global Targeted Therapy Drugs Sales (M Units) by Type (2021–2026)
Table 53. Global Targeted Therapy Drugs Sales (M Units) by Type (2027–2032)
Table 54. Global Targeted Therapy Drugs Sales Market Share by Type (2021–2026)
Table 55. Global Targeted Therapy Drugs Sales Market Share by Type (2027–2032)
Table 56. Global Targeted Therapy Drugs Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Targeted Therapy Drugs Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Targeted Therapy Drugs Revenue Market Share by Type (2021–2026)
Table 59. Global Targeted Therapy Drugs Revenue Market Share by Type (2027–2032)
Table 60. Global Targeted Therapy Drugs Price (US$/Unit) by Type (2021–2026)
Table 61. Global Targeted Therapy Drugs Price (US$/Unit) by Type (2027–2032)
Table 62. Global Targeted Therapy Drugs Sales (M Units) by Application (2021–2026)
Table 63. Global Targeted Therapy Drugs Sales (M Units) by Application (2027–2032)
Table 64. Global Targeted Therapy Drugs Sales Market Share by Application (2021–2026)
Table 65. Global Targeted Therapy Drugs Sales Market Share by Application (2027–2032)
Table 66. Global Targeted Therapy Drugs Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Targeted Therapy Drugs Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Targeted Therapy Drugs Revenue Market Share by Application (2021–2026)
Table 69. Global Targeted Therapy Drugs Revenue Market Share by Application (2027–2032)
Table 70. Global Targeted Therapy Drugs Price (US$/Unit) by Application (2021–2026)
Table 71. Global Targeted Therapy Drugs Price (US$/Unit) by Application (2027–2032)
Table 72. Roche Company Information
Table 73. Roche Description and Business Overview
Table 74. Roche Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 75. Roche Targeted Therapy Drugs Product
Table 76. Roche Recent Developments/Updates
Table 77. Novartis Company Information
Table 78. Novartis Description and Business Overview
Table 79. Novartis Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 80. Novartis Targeted Therapy Drugs Product
Table 81. Novartis Recent Developments/Updates
Table 82. Merck Company Information
Table 83. Merck Description and Business Overview
Table 84. Merck Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 85. Merck Targeted Therapy Drugs Product
Table 86. Merck Recent Developments/Updates
Table 87. Pfizer Company Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 90. Pfizer Targeted Therapy Drugs Product
Table 91. Pfizer Recent Developments/Updates
Table 92. AstraZeneca Company Information
Table 93. AstraZeneca Description and Business Overview
Table 94. AstraZeneca Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 95. AstraZeneca Targeted Therapy Drugs Product
Table 96. AstraZeneca Recent Developments/Updates
Table 97. Johnson & Johnson Company Information
Table 98. Johnson & Johnson Description and Business Overview
Table 99. Johnson & Johnson Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 100. Johnson & Johnson Targeted Therapy Drugs Product
Table 101. Johnson & Johnson Recent Developments/Updates
Table 102. Bristol Myers Squibb Company Information
Table 103. Bristol Myers Squibb Description and Business Overview
Table 104. Bristol Myers Squibb Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 105. Bristol Myers Squibb Targeted Therapy Drugs Product
Table 106. Bristol Myers Squibb Recent Developments/Updates
Table 107. Bayer Company Information
Table 108. Bayer Description and Business Overview
Table 109. Bayer Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 110. Bayer Targeted Therapy Drugs Product
Table 111. Bayer Recent Developments/Updates
Table 112. GSK Company Information
Table 113. GSK Description and Business Overview
Table 114. GSK Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 115. GSK Targeted Therapy Drugs Product
Table 116. GSK Recent Developments/Updates
Table 117. Daiichi Sankyo Company Information
Table 118. Daiichi Sankyo Description and Business Overview
Table 119. Daiichi Sankyo Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 120. Daiichi Sankyo Targeted Therapy Drugs Product
Table 121. Daiichi Sankyo Recent Developments/Updates
Table 122. Amgen Company Information
Table 123. Amgen Description and Business Overview
Table 124. Amgen Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 125. Amgen Targeted Therapy Drugs Product
Table 126. Amgen Recent Developments/Updates
Table 127. Eli Lilly and Company Company Information
Table 128. Eli Lilly and Company Description and Business Overview
Table 129. Eli Lilly and Company Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 130. Eli Lilly and Company Targeted Therapy Drugs Product
Table 131. Eli Lilly and Company Recent Developments/Updates
Table 132. AbbVie Company Information
Table 133. AbbVie Description and Business Overview
Table 134. AbbVie Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 135. AbbVie Targeted Therapy Drugs Product
Table 136. AbbVie Recent Developments/Updates
Table 137. Sanofi Company Information
Table 138. Sanofi Description and Business Overview
Table 139. Sanofi Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 140. Sanofi Targeted Therapy Drugs Product
Table 141. Sanofi Recent Developments/Updates
Table 142. Takeda Company Information
Table 143. Takeda Description and Business Overview
Table 144. Takeda Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 145. Takeda Targeted Therapy Drugs Product
Table 146. Takeda Recent Developments/Updates
Table 147. Boehringer Ingelheim Company Information
Table 148. Boehringer Ingelheim Description and Business Overview
Table 149. Boehringer Ingelheim Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 150. Boehringer Ingelheim Targeted Therapy Drugs Product
Table 151. Boehringer Ingelheim Recent Developments/Updates
Table 152. Beigene, Ltd. Company Information
Table 153. Beigene, Ltd. Description and Business Overview
Table 154. Beigene, Ltd. Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 155. Beigene, Ltd. Targeted Therapy Drugs Product
Table 156. Beigene, Ltd. Recent Developments/Updates
Table 157. Jiangsu Hengrui Medicine Company Information
Table 158. Jiangsu Hengrui Medicine Description and Business Overview
Table 159. Jiangsu Hengrui Medicine Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 160. Jiangsu Hengrui Medicine Targeted Therapy Drugs Product
Table 161. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 162. INNOVENT BIOLOGICS(SUZHOU) Company Information
Table 163. INNOVENT BIOLOGICS(SUZHOU) Description and Business Overview
Table 164. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 165. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs Product
Table 166. INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
Table 167. Betta Pharmaceuticals Company Information
Table 168. Betta Pharmaceuticals Description and Business Overview
Table 169. Betta Pharmaceuticals Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 170. Betta Pharmaceuticals Targeted Therapy Drugs Product
Table 171. Betta Pharmaceuticals Recent Developments/Updates
Table 172. Remegen Co.,Ltd. Company Information
Table 173. Remegen Co.,Ltd. Description and Business Overview
Table 174. Remegen Co.,Ltd. Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 175. Remegen Co.,Ltd. Targeted Therapy Drugs Product
Table 176. Remegen Co.,Ltd. Recent Developments/Updates
Table 177. Shanghai Allist Pharmaceuticals Company Information
Table 178. Shanghai Allist Pharmaceuticals Description and Business Overview
Table 179. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 180. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs Product
Table 181. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 182. Innocare Company Information
Table 183. Innocare Description and Business Overview
Table 184. Innocare Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 185. Innocare Targeted Therapy Drugs Product
Table 186. Innocare Recent Developments/Updates
Table 187. Huiyu Pharmaceuticals Company Information
Table 188. Huiyu Pharmaceuticals Description and Business Overview
Table 189. Huiyu Pharmaceuticals Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 190. Huiyu Pharmaceuticals Targeted Therapy Drugs Product
Table 191. Huiyu Pharmaceuticals Recent Developments/Updates
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Targeted Therapy Drugs Distributors List
Table 195. Targeted Therapy Drugs Customers List
Table 196. Targeted Therapy Drugs Market Trends
Table 197. Targeted Therapy Drugs Market Drivers
Table 198. Targeted Therapy Drugs Market Challenges
Table 199. Targeted Therapy Drugs Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
Table 203. Authors List of This Report
List of Figures
Figure 1. Product Picture of Targeted Therapy Drugs
Figure 2. Global Targeted Therapy Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Targeted Therapy Drugs Market Share by Type: 2025 & 2032
Figure 4. Kinase Inhibitors Product Picture
Figure 5. ADC Product Picture
Figure 6. Others Product Picture
Figure 7. Global Targeted Therapy Drugs Market Value by Administration Route (US$ Million), 2021–2032
Figure 8. Global Targeted Therapy Drugs Market Share by Administration Route: 2025 vs 2032
Figure 9. Oral Drugs Product Picture
Figure 10. Injectable Drugs Product Picture
Figure 11. Others Product Picture
Figure 12. Global Targeted Therapy Drugs Market Value by Molecular Properties (US$ Million), 2021–2032
Figure 13. Global Targeted Therapy Drugs Market Share by Molecular Properties: 2025 vs 2032
Figure 14. Small Molecule Drugs Product Picture
Figure 15. Antibody Drugs Product Picture
Figure 16. Others Product Picture
Figure 17. Global Targeted Therapy Drugs Market Value by Application (US$ Million), 2021–2032
Figure 18. Global Targeted Therapy Drugs Market Share by Application: 2025 & 2032
Figure 19. Cancer
Figure 20. Rare Diseases
Figure 21. Others
Figure 22. Global Targeted Therapy Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Targeted Therapy Drugs Market Size (US$ Million), 2021–2032
Figure 24. Global Targeted Therapy Drugs Sales (M Units), 2021–2032
Figure 25. Global Targeted Therapy Drugs Average Price (US$/Unit), 2021–2032
Figure 26. Targeted Therapy Drugs Report Years Considered
Figure 27. Targeted Therapy Drugs Sales Share by Manufacturers in 2025
Figure 28. Global Targeted Therapy Drugs Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Targeted Therapy Drugs Players: Market Share by Revenue in Targeted Therapy Drugs in 2025
Figure 30. Targeted Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Targeted Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
Figure 33. North America Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
Figure 34. United States Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
Figure 37. Europe Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
Figure 38. Germany Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Targeted Therapy Drugs Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Targeted Therapy Drugs Revenue Market Share by Region (2021–2032)
Figure 45. China Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. China Taiwan Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Southeast Asia Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
Figure 53. Latin America Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Colombia Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Middle East and Africa Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
Figure 59. Middle East and Africa Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
Figure 60. Turkey Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. Saudi Arabia Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. UAE Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Global Sales Market Share of Targeted Therapy Drugs by Type (2021–2032)
Figure 64. Global Revenue Market Share of Targeted Therapy Drugs by Type (2021–2032)
Figure 65. Global Targeted Therapy Drugs Price (US$/Unit) by Type (2021–2032)
Figure 66. Global Sales Market Share of Targeted Therapy Drugs by Application (2021–2032)
Figure 67. Global Revenue Market Share of Targeted Therapy Drugs by Application (2021–2032)
Figure 68. Global Targeted Therapy Drugs Price (US$/Unit) by Application (2021–2032)
Figure 69. Targeted Therapy Drugs Value Chain
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
